Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
NCT ID: NCT02678884
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2014-10-31
2028-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
NCT00721799
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01179360
MRI and PET-CT for Radiotherapy Planning for Head and Neck Cancer
NCT02273778
A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients
NCT01506427
PET With [18F]HX4 in Head and Neck Cancer
NCT01347281
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HNSCC Patients receiving RT
18-F FDG
All patients enrolled in this study will receive 2 PET Scans: One prior to Radiation, and one during Radiation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
18-F FDG
All patients enrolled in this study will receive 2 PET Scans: One prior to Radiation, and one during Radiation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Radiologically evident gross disease
* Radiotherapy alone for curative intent
* Age equal to or more than 18 years old
* To be eligible for the second study PET-CT scan: FDG avid tumour (or minimum SUV of 2.5) on the first study PET-CT scan
Exclusion Criteria
* H\&N SCC skin
* Distant metastases (already known or if found on baseline CT-thorax)
* Prior malignancy within the last 5 years (exclude non-H\&N SCC, BCC skin)
* Prior chemotherapy within the last 5 years or concurrent chemotherapy/EGFR inhibitors
* Prior head and neck radiotherapy
* Inability to lie supine for study duration
* Pregnancy
* Inability to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John J Kim, MD
Role: PRINCIPAL_INVESTIGATOR
The Princess Margaret Cancer Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Health Network, Princess Margaret Cancer Center
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHN REB 12-5378-CE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.